Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Tew

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2018
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric OncologySupriya G Mohile, William Dale, Mark R Somerfield, et al.
Journal of Cancer Survivorship : Research and Practice|April 28, 2024
Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective studyMina S Sedrak, Can-Lan Sun, Marie Bae, et al.
Gynecologic Oncology|January 20, 2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide managementYing L Liu, Beryl L Manning-Geist, Andrea Knezevic, et al.
The Oncologist|March 19, 2022
Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal CancersDaneng Li, Can-Lan Sun, Rebecca Allen, et al.
JCO Oncology Practice|April 21, 2021
Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer ChemotherapyHeidi D Klepin, Can-Lan Sun, David D Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE TrialMina S Sedrak, Can-Lan Sun, Jingran Ji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2022
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III TrialJoyce F Liu, Mark F Brady, Ursula A Matulonis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial CancerMaria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Gynecologic Oncology|May 6, 2023
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary studyTiffany Y Sia, William P Tew, Christopher Purdy, et al.
Gynecologic Oncology|August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2018
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric OncologySupriya G Mohile, William Dale, Mark R Somerfield, et al.
Journal of Cancer Survivorship : Research and Practice|April 28, 2024
Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective studyMina S Sedrak, Can-Lan Sun, Marie Bae, et al.
Gynecologic Oncology|January 20, 2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide managementYing L Liu, Beryl L Manning-Geist, Andrea Knezevic, et al.
The Oncologist|March 19, 2022
Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal CancersDaneng Li, Can-Lan Sun, Rebecca Allen, et al.
JCO Oncology Practice|April 21, 2021
Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer ChemotherapyHeidi D Klepin, Can-Lan Sun, David D Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE TrialMina S Sedrak, Can-Lan Sun, Jingran Ji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2022
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III TrialJoyce F Liu, Mark F Brady, Ursula A Matulonis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial CancerMaria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Gynecologic Oncology|May 6, 2023
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary studyTiffany Y Sia, William P Tew, Christopher Purdy, et al.
Gynecologic Oncology|August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.
Pageof 12